Market Capitalization (Millions $) |
106,240 |
Shares
Outstanding (Millions) |
261 |
Employees |
3,900 |
Revenues (TTM) (Millions $) |
9,869 |
Net Income (TTM) (Millions $) |
3,620 |
Cash Flow (TTM) (Millions $) |
-140 |
Capital Exp. (TTM) (Millions $) |
258 |
Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Inc. is a biotechnology company that focuses on discovering, developing, and commercializing innovative medicines for serious diseases. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
Vertex Pharmaceuticals Inc. has become a leading player in the field of cystic fibrosis, a genetic disease that affects the lungs and other organs. The company's first drug, Kalydeco, was approved in 2012 and was the first drug to treat the underlying cause of cystic fibrosis in patients with a specific genetic mutation. Since then, Vertex Pharmaceuticals Inc. has developed other drugs for cystic fibrosis, including Orkambi and Symdeko, which have greatly improved the lives of patients.
Aside from its work in cystic fibrosis, Vertex Pharmaceuticals Inc. is also exploring other therapeutic areas, including sickle cell disease, beta thalassemia, and pain management. The company's research and development efforts are focused on small molecules and gene therapies, with the goal of developing precision medicines that target the underlying cause of diseases.
In addition to its drug development efforts, Vertex Pharmaceuticals Inc. is committed to corporate social responsibility. The company has a strong commitment to environmental sustainability and works to reduce its carbon footprint through energy conservation, recycling, and sustainable building practices. The company is also committed to supporting patient advocacy groups and has established programs to help patients access its medications.
Overall, Vertex Pharmaceuticals Inc. is a company that is dedicated to developing innovative medicines for serious diseases, while also maintaining a strong commitment to corporate social responsibility. With its cutting-edge research, talented team of scientists and clinicians, and commitment to patients and the community, Vertex Pharmaceuticals Inc. is poised to continue making a significant impact in the field of biotechnology.
Company Address: 50 Northern Avenue Boston 2210 MA
Company Phone Number: 341-6100 Stock Exchange / Ticker: NASDAQ VRTX
|